Background: Gastritis results from multifactorial gastric mucosal injury. Helicobacter pylori(Hp) is the main cause, and associated diseases have typical underlying patterns of gastritis. Gastric ulcer and gastric cancer (GC) develop from chronic atrophic corpus gastritis (CAG) which therefore represents the most important pattern. GC incidences in East Asia are substantially higher than elsewhere, and this should be also reflected by higher prevalences of CAG and characteristic differences in pathophysiology compared to the West. Summary: The few available comparative studies of gastritis in Eastern and Western patients are summarized. The main pathogenic factors of gastritis are discussed together with their limitations to explain local differences in disease outcome. Emphasis was put to also include less well-established pathogenic host and environmental factors of possible impact. Conclusions: CAG is more prevalent in East Asian areas with high GC incidences than the West. Geographic heterogeneity of associated diseases is due to differences in Hp prevalence and virulence as well as modulating host and environmental factors. The following may contribute to the higher burden of CAG in the East: ABD type of CagA with vacA s1 and babA2 alleles of Hp, host Lewis(b) expression in sej/sej nonsecretors, H. heilmannii, low parietal cell mass, high sodium and nitrate intake, preferences in vegetable and fruit consumption, cigarette smoking, air pollution, alcohol. Conversely, green tea, nonfermented soy products and rice may confer protective effects. Hp is on the decline, but also in a world cleared from this bacterium, differences in host genetics will continue to modify gastric disease outcome together with maintained customs as part of cultural diversity.

Keywords:
Helicobacter pylori, Chronic atrophic gastritis, Pathogenic factors
1.
Siurala M, Varis K, Wiljasalo M: Studies of patients with atrophic gastritis: a 10- to 15-year follow-up. Scand J Gastroenterol 1966;1:40-48.
2.
Walker IR, Strickland RG, Ungar B, et al: Simple atrophic gastritis and gastric carcinoma. Gut 1971;12:906-911.
3.
Correa P, Haenszel W, Cuello C, et al: A model of gastric cancer epidemiology. Lancet 1975; 2:58-60.
4.
Sipponen P, Kimura K: Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time. Eur J Gastroenterol Hepatol 1994;6(suppl 1):79-83.
5.
Sipponen P, Marshall BJ: Gastritis and gastric cancer. Western countries. Gastroenterol Clin North Am 2000;29:579-592.
6.
Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996;20:1161-1181.
7.
Rugge M, Fassan M, Pizzi M, et al: Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther 2012;35:1460-1466.
8.
Jönsson KA, Ström M, Bodemar G, et al: Histologic changes in gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol 1988;23:433-441.
9.
Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al: Atrophic gastritis and Helicobacterpylori infection in patients with reflux gastritis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-1022.
10.
Sugano K, Tack J, Kuipers EJ, et al: Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015;64:1353-1367.
11.
Hunt RH, Camilleri M, Crowe SE, et al: The stomach in health and disease. Gut 2015;64:1650-1668.
12.
Rugge M, Fassan M, Pizzi M, et al: Operative link for gastritis assessment vs operative link of intestinal metaplasia assessment. World J Gastroenterol 2011;17:4596-4601.
13.
Stickland RG, Mackay IR: A reappraisal of the nature and significance of chronic atrophic gastritis. Dig Dis 1973;18:426-440.
14.
Wyatt JI, Dixon MF: Chronic gastritis - a pathogenetic approach. J Pathol 1988;154:113-124.
15.
Kohli Y, Pfeiffer CJ, Kutty KP et al: Endoscopic diagnosis of intestinal metaplasia in Canada and Japan. J Clin Gastroenterol 1981;3(suppl 1):29-33.
16.
Schlemper RJ, van der Werf SD, Vandenbroucke JP, et al: Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori. Gut 1995;37:199-204.
17.
Chen XY, van der Hulst RW, Shi Y, et al: Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients. J Clin Pathol 2001;54:367-370.
18.
El-Zimaity HM, Gutierrez O, Kim JG, et al: Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol 2001;96:666-672.
19.
Kimura K, Sipponen P, Unge P, et al: Comparison of gastric histology among Swedish and Japanese patients with peptic ulcer and Helicobacter pylori infection. Scand J Gastroenterol 2003;38:491-497.
20.
Lee I, Lee H, Kim M, et al: Ethnic difference of Helicobacter pylori gastritis: Korean and Japanese gastritis is characterized by male- and antrum-predominant acute foveolitis in comparison with American gastritis. World J Gastroenterol 2005;11:94-98.
21.
Naylor GM, Gotoda T, Dixon M, et al: Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006;55:1545-1552.
22.
Siurala M, Sipponen P, Kekki M: Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol 1985;109:69-76.
23.
Wang WH, Huang JQ, Zheng GF, et al: Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2003;95:1784-1791.
24.
Tan VP, Wong BC: Gastric cancer chemoprevention: the current evidence. Gastroenterol Clin North Am 2013;42:299-313.
25.
Iijima K, Ohara S, Koike T, et al: Gastric acid secretion of normal Japanese subjects in relation to Helicobacter pylori infection, aging, and gender. Scand J Gastroenterol 2004;39:709-716.
26.
Kimura K: Gastritis and gastric cancer. Asia. Gastroenterol Clin North Am 2000;29:609-621.
27.
Blaser MJ, Kobayashi K, Cover TL, et al: Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer 1993;55:799-802.
28.
Watanabe Y, Kurata JH, Mizuno S, et al: Helicobacter pylori infection and gastric cancer: a nested case-control study in a rural area of Japan. Dig Dis Sci 1997;42:1383-1387.
29.
Fukuda H, Saito D, Hayashi S, et al: Helicobacter pylori infection, serum pepsinogen levels and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 1995;86:64-71.
30.
Fukao A, Komatsu S, Tsubono Y, et al: Helicobacter pylori infection and atrophic gastritis among Japanese blood donors: a cross-sectional study. Cancer Causes Control 1993;4:307-312.
31.
Ohata H, Kitauchi S, Yoshimura N, et al: Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-143.
32.
Kato I, Vivas J, Plummer M, et al: Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev 2004;13:468-476.
33.
Da Costa DM, dos Santos Pereira E, Barem Rabenhorst SH: What exist beyond cagA and vacA? Helicobacterpylori genes in gastric disease. World J Gastroenterol 2015;21:10563-10572.
34.
Fujimoto S, Olaniyi O, Arnqvist A: Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol 2007;5:49-58.
35.
Graham DY: Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997;113:1983-1991.
36.
Graham DY, Lu H, Yamaoka Y: African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts and medical myths. J Dig Dis 2009;10:77-84.
37.
Cover TL, Peek RM: Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes 2013;4:482-493.
38.
Graham DY: History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol 2014;20:5191-5204.
39.
Ito Y, Azuma T, Ito S, et al: Analysis and typing of the vacA gene from cagA-positive strains of Helicobacterpylori isolated in Japan. J Clin Microbiol 1997;35:1710-1714.
40.
Higashi H, Tsutsumi R, Muto S, et al: SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002;295:683-686.
41.
Sahara S, Sugimoto M, Vilaichone RK, et al: Role of Helicobacter pyloricagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis. BMC Infect Dis 2012;12:223-236.
42.
Acosta N, Quiroga A, Delgado P, et al: Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis. World J Gastroenterol 2010;16:3936-3943.
43.
Matsuhisa T, Yamaoka Y, Uchida T, et al: Gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection. World J Gastroenterol 2015;21:8408-8417.
44.
El-Omar EM, Carrinton M, Chow WH, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
45.
Furuta T, El-Omar EM, Xiao F, et al: Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002;123:92-105.
46.
Shin WG, Jang JS, Kim HS, et al: Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea. J Gastroenterol Hepatol 2008;23:1567-1573.
47.
Kamangar F, Cheng C, Abnet CC, et al: Interleukin-1B polymorphisms and gastric cancer risk - a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1920-1928.
48.
Sonnenberg A: Dietary salt and gastric ulcer. Gut 1986;27:1138-1142.
49.
Haruma K: Trend toward a reduced prevalence of Helicobacter pylori infection, chronic gastritis, and gastric cancer in Japan. Gastroenterol Clin North Am 2000;29:623-631.
50.
Kamada T, Haruma K, Ito M, et al: Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan. Helicobacter 2015;20:192-198.
51.
Correa P: The epidemiology and pathogenesis of chronic gastritis: three etiologic entities. Front Gastrointest Res 1980;6:98-108.
52.
Shibata K, Moriyama M, Fukushima T, et al: Relation of Helicobacter pylori infection and lifestyle to the risk of chronic atrophic gastritis: a cross-sectional study in Japan. J Epidemiol 2002;12:105-111.
53.
Kimura K, Takemoto T: An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;3:87-97.
54.
Kimura K: Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvature of the stomach. Gastroenterology 1972;63:584-592.
55.
Correa P, Schmidt BA: The relationship between gastric cancer frequency and the ratio of gastric to duodenal ulcer. Aliment Pharmacol Ther 1995;9(suppl 2):13-19.
56.
Colquhoun A, Arnold M, Ferlay J, et al: Global pattern of cardia and non-cardia gastric cancer incidence in 2012. Gut 2015;64:1881-1888.
57.
You WC, Blot WJ, Li JY, et al: Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993;53:1317-1321.
58.
De Martel C, Forman D, Plummer M: Gastric cancer. Epidemiology and risk factors. Gastroenterol Clin North Am 2013;42:219-240.
59.
Park YH, Kim N: Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev 2015;20:25-40.
60.
Cardenas-Mondragon MG, Torres J, Flores-Luna L, et al: Epstein-Barr virus association with peptic ulcer disease. Anal Cell Pathol (Amst) 2015;2015:164840.
61.
Murphy G, Pfeiffer R, Camargo MC, et al: Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009;137:824-833.
62.
Salazar CR, Sun J, Li Y, et al: Association between selected oral pathogens and gastric precancerous lesions. PLoS One 2013;8:e51604.
63.
Bento-Miranda M, Figueiredo C: Helicobacter heilmannii sensu lato: an overview of the infection in humans. World J Gastroenterol 2014;21:17779-17787.
64.
Tan P, Yeoh KG: Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology 2015;149:1153-1162.
65.
Sipponen P, Hyvarinen H, Siurala M: H. pylori corpus gastritis - relation to acid output. J Physiol Pharmacol 1996;47:151-159.
66.
Stadelmann O, Elster K, Stolte M, et al: the peptic gastric ulcer - histotopographic and functional investigations. Scand J Gastroenterol 1971;6:613-623.
67.
Lam SK, Hasan M, Sircus W, et al: Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980;21:324-328.
68.
Cheng FC, Lam SK, Ong GB: Maximum acid output to graduated doses of pentagastrin and its relation to parietal cell mass in Chinese patients with duodenal ulcer. Gut 1977;18:827-832.
69.
Card WI, Mark IN: The relationship between the acid output of the stomach following ‘maximal' histamine stimulation and the parietal cell mass. Clin Sci 1960;19:147-163.
70.
Leong RW: Differences in peptic ulcer between the East and the West. Gastroenterol Clin North Am 2009;38:363-379.
71.
Iijima K, Shimosegawa T: Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury. World J Gastroenterol 2015;21:7709-7717.
72.
Blackwell CC: The role of AB0 blood groups and secretor status in host defences. FEMS Microbiol Immunol 1989;47:341-350.
73.
Le Pendu J, Lemieux RU, Lambert F, et al: Distribution of H type 1 and H type 2 antigenic determinants in human sera and saliva. Am J Hum Genet 1982;24:402-415.
74.
Oriol R, Le Pendu J, Mollicone R: Genetics of AB0, H, Lewis, X and related antigens. Vox Sang 1986;51:161-171.
75.
Henry S, Oriol R, Samuelsson BE: Lewis histo-blood group system and associated secretory phenotypes. Vox Sang 1995;69:166-182.
76.
Vesely KT, Kubickova Z, Dvorakova M, et al: Clinical data and characteristics differentiating types of peptic ulcer. Gut 1968;9:57-68.
77.
Aird I, Bentall HH, Fraser R: A relationship between cancer of stomach and the AB0 blood groups. BMJ 1953;1:799-801.
78.
Kneller RW, You WC, Chang YS, et al: Cigarette smoking and other risk factors for progression of precancerous stomach lesion. J Natl Cancer Inst 1992;84:1261-1266.
79.
Edgren G, Hjalgrim H, Rostgaard K, et al: Risk of gastric cancer and peptic ulcer in relation to AB0 blood type: a cohort study. Am J Epidemiol 2010;172:1280-1285.
80.
Sipponen P Aärynen M, Kääriäinen I, et al: Chronic antral gastritis, Lewis (a+) phenotype, and male sex as factors in predicting coexisting duodenal ulcer. Scand J Gastroenterol 1989;24:581-588.
81.
Aspinall GO, Monteiro MA, Pang H, et al: O antigen chains in the lipopolysaccharide of H. pylori NCTC 11637. Carbohydr Lett 1994;1:151-156.
82.
Borén T, Falk P, Roth KA, et al: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892-1895.
83.
Ilver D, Arnquist A, Oeren J, et al: Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998;279:373-377.
84.
Mahdavi J, Sonden B, Hurtig M, et al: Helicobacter pylori SabA adhesion in persistent infection and chronic inflammation. Science 2002;297:573-578.
85.
Gerhard M, Lehn N, Neumayer N, et al: Clinical relevance of the Helicobacter pylori gene for blood-group antigen binding adhesin. Proc Natl Acad Sci USA 1999;96:12778-12783.
86.
Clyne M, Drumm B: Absence of effect of Lewis A and Lewis B expression on adherence of Helicobacter pylori to human gastric cells. Gastroenterology 1997;113:72-80.
87.
Chen MY, He CY, Meng X, et al: Association of Helicobacter pylori babA2 with peptic ulcer disease and gastric cancer. World J Gastroenterol 2013;14:4242-4251.
88.
Kudo T, Iwasaki H, Nishihara S, et al: Molecular genetic analysis of the human Lewis histo-blood group system. J Biol Chem 1996;271:9830-9837.
89.
Ikehara Y, Nishihara S, Yasutomi H, et al: Polymorphisms of two fucosyltransferase genes (Lewis and secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol Biomarkers Prev 2001;10:971-977.
90.
Yamaoka Y, Ojo O, Fujimoto S, et al: Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006;55:775-781.
91.
Sheu BS, Odenbreit S, Hung KH, et al: Interaction between host gastric Sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen. Am J Gastroenterol 2006;101:36-44.
92.
Yamaoka Y: Increasing evidence of the role of Helicobacter pylori SabA in the pathogenesis of gastroduodenal disease. J Infect Dev Ctries 2008;2:174-181.
93.
Salama NR, Hartung M, Müller A: Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Micobiol 2013;11:385-399.
94.
Ruiz B, Rood JC, Fontham ET, et al: Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994;89:533-539.
95.
Edwards FC, Coghill NF: Aetiological factors in chronic atrophic gastritis. BMJ 1966;2:1409-1415.
96.
Jainan W, Vilaichone RK: Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer. Asian Pac J Prev 2014;15:10957-10960.
97.
Hofner P, Gyulai Z, Kiss ZF, et al: Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 2007;12:124-131.
98.
Pan KF, Zhang L, Gerhard M, et al: A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu county, China: baseline results and factors affecting the eradication. Gut 2016;65:9-18.
99.
Wright ME, Andreotti G, Lissowska J, et al: Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur J Cancer 2009;45:1824-1830.
100.
Duell EJ, Lujan-Barroso L, Llivian C, et al: Vitamin C transporter gene (SCL23A1 and SCL23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohort. Genes Nutr 2013;8:549-560.
101.
Santolaria S, Barrios Y, Benito R, et al: Helicobacter pylori and immunogenic factors of the host: relevance of the HLADQA1 *0102 and *0301 alleles in peptic ulcer. Gastroenterol Hepatol 2001;24:117-121.
102.
Mayerle J, den Hoed CM, Schurmann C, et al: Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 2013;309:1912-1920.
103.
Palli D, Decarli A, Cipriani F, et al: Plasma pepsinogens, nutrients, and diet in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomarker Prev 1991;1:45-50.
104.
Ikeda F, Doi Y, Yonemoto K, et al: Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 2009;136:1234-1241.
105.
Stemmermann G, Haenszel W, Locke F: Epidemiologic pathology of gastric ulcer and gastric carcinoma among Japanese in Hawaii. J Natl Cancer Inst 1977;58:13-20.
106.
Tsugane S: Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005;96:1-6.
107.
Wang XQ, Terry PD, Yan H: Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol 2009;15:2204-2213.
108.
Munoz N, Plummer M, Viva J, et al: A case-control study of gastric cancer in Venezuela. Int J Cancer 2001;93:417-423.
109.
Joossens JV, Hill MJ, Elliott P, et al: Dietary salt, nitrate and stomach cancer mortality in 24 countries. Int J Epidemiol 1996;25:494-504.
110.
D'Elia L, Rossi G, Ippolito R, et al: Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012;31:489-498.
111.
MacDonald WC, Anderson FH, Hashimoto S: Histological effect of certain pickles on the human gastric mucosa. A preliminary report. Can Med Assoc 1967;96:1521-1525.
112.
Stemmermann GN, Nomura AM, Chyou PH, et al: Impact of diet and smoking on risk of developing intestinal metaplasia of the stomach. Dig Dis Sci 1990;35:433-438.
113.
Montani A, Sasazuki S, Inoue M, at al: Food/nutrient intake and risk of atrophic gastritis among the Helicobacter pylori-infected population of northeastern Japan. Cancer Sci 2003;94:372-377.
114.
Tsugane S, Kabuto M, Imai H, et al: Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different cancer mortality. Cancer Causes Control 1993;4:297-305.
115.
Gonzales CA, Jakszyn P, Pera G, et al: Meat intake and risk of stomach and esophageal adenocarcinoma within the European prospective investigation into cancer and nutrition (EPIC). J Nat Cancer Inst 2006;98:345-354.
116.
Key TJ, Appleby PN, Crowe FL, et al: Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans. Am J Clin Nutr 2014;100(suppl):378S-385S.
117.
Fontham ET, Zavala D, Correa P, et al: Diet and chronic atrophic gastritis: a case-control study. J Natl Cancer Inst 1986;76;621-627.
118.
Freedman ND, Subar AF, Hollenbeck AR, et al: Fruit and vegetable intake and gastric cancer in a large United States prospective cohort study. Cancer Causes Control 2008;19:459-467.
119.
Bradbury KE, Appleby PN, Key TJ: Fruit, vegetables, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutriton (EPIC). Am J Nutr 2014;100(suppl):394S-398S.
120.
Aditi A, Graham DY: Vitamin C, gastritis, and gastric disease: a historical review and update. Dig Dis Sci 2012;57:1-22.
121.
Sobala GM, Schorah CJ, Shires S, et al: Effect eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993;34:1038-1041.
122.
Wong BC, Ching CK, Lam SK, et al: Differential north to south gastric cancer-duodenal ulcer gradient in China. J Gastroenterol Hepatol 1998;13:1050-1057.
123.
Rokkas T, Papatheodorou G, Karameris A, et al: Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication. Dig Dis Sci 1995;40:615-621.
124.
Rood JC, Ruiz B, Fontham ET, et al: Helicobacter pylori-associated gastritis and the ascorbic acid concentrations in gastric juice. Nutr Cancer 1994;22:65-72.
125.
Goodman KJ, Correa P, Tengana HJ, et al: Nutritional factors and Helicobacter pylori infection in Colombian children. J Pediatr Gastroenterol Nutr 1997;25:507-515.
126.
Correa P, Fontham ET, Bravo JC, et al: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-1888.
127.
Harrison LE, Zhang ZF, Karpeh MS, et al: The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer 1997;80:1021-1028.
128.
Zhang Z, Xu G, Ma M, et al: Dietary fiber intake reduces risk for gastric cancer: a meta-analysis. Gastroenterology 2013;145:113-120.
129.
Guo Y, Shan Z, Ren H, et al: Dairy consumption and gastric cancer risk: a meta-analysis of epidemiological studies. Nutr Cancer 2015;67:555-568.
130.
Tovey FI, Hobsley M, Kaushik SP, et al: Duodenal gastric metaplasia and Helicobacter pylori infection in high and low duodenal ulcer-prevalent areas in India. J Gastroenterol Hepatol 2004;19:424-430.
131.
Nagata C, Takatsuka N, Kawakami N, et al: A prospective cohort study of soy product intake and stomach cancer death. Br J Cancer 2002;87:31-36.
132.
Ko KP, Park SK, Yang JJ, et al: Intake of soy products and other foods and gastric cancer risk: a prospective study. J Epidemiol 2013;23:337-343.
133.
Wu SH, Shu XO, Chow WH, et al: Soy food intake and circulating levels of inflammatory markers in Chinese women. J Acad Nutr Diet 2012;112:996-1004.
134.
Kamo S, Suzuki S, Sato T: The content of soyasaponin and soyasapogenol in soy foods and their estimated intake in the Japanese. Food Sci Nutr 2014;2:289-297.
135.
Jorgensen TR: Identification and toxigenic potential of industrially important fungi, Aspergillus oryzae and Aspergillus sojae. J Food Prot 2007;70:2916-2934.
136.
Kweon SS, Shu XO, Xiang Y, et al: Intake of specific non-fermented soy foods may be inversely associated with risk of distal gastric cancer in a Chinese population. J Nutr 2013;143:1736-1742.
137.
Gonzalez CA, Pera G, Agudo A, et al: Smoking and the risk of gastric cancer in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2003;107:629-634.
138.
Trédaniel J, Boffetta P, Buiatti E, et al: Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 1997;72:565-573.
139.
Lareidas-Lopes R, Pereira AK, Nogueira A, et al: Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008;19:689-701.
140.
Siman JH, Fosgren A, Berglund G, et al: Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals. Scand J Gastroenterol 2001;36:208-213.
141.
Rosenstock S, Jorgensen T, Bonnevie O, et al: Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut 2003;52:186-193.
142.
Wong BC, Lam SK, Wong WM, et al: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. JAMA 2004;291:187-194.
143.
Müller-Lissner SA: Bile reflux is increased in cigarette smokers. Gastroenterology 1986;90:1205-1209.
144.
Nakamura M, Haruma K, Kamada T, et al: Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects. Dig Dis Sci 2002;47:675-681.
145.
Shimoyama T, Everett SM, Fukuda S, et al: Influence of smoking and alcohol on gastric chemokine mRNA expression in patients with Helicobacter pylori infection. J Clin Pathol 2001;54:332-334.
146.
Chiu HF, Tsa SS, Chen PS, et al: Traffic air pollution and risk of death from gastric cancer in Taiwan: petrol station density as an indicator of air pollution exposure. J Toxicol Environ Health 2011;74:1215-1224.
147.
Tramacere I, Negri E, Pelucchi C, et al: A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 2012;23:23-28.
148.
Shibata K, Moriyama M, Fukushima T, et al: Green tea consumption and chronic atrophic gastritis: a cross-sectional study in a green tea production village. J Epidemiol 2000;10:310-316.
149.
Kuwahara Y, Kono S, Eguchi H, et al: Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men. Scand J Gastroenterol 2000;35:476-481.
150.
Edwards FC, Edwards JH: Tea drinking and gastritis. Lancet 1956;271:543-545.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.